Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$87.24 USD
-2.81 (-3.12%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $87.22 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 37% (92 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.16 | 1.57 | 9.99 |
Current Quarter Estimate | 0.64 | 3.93 | 60.00 |
Year Ago Quarter Estimate | 0.62 | 3.85 | 52.54 |
Next Quarter Estimate | 0.70 | 3.92 | 61.00 |
Next Year Estimate | 3.10 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 9.96 | 14.50 | 17.08 |
Next Year | 12.32 | 22.30 | 8.00 |
Last 5 Years | 9.90 | 10.00 | 8.10 |
Next 5 Years | 7.30 | 14.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 35.88 | 29.13 |
Price/Book (MRQ) | 8.13 | 2.42 |
Price/Cash Flow (MRFY) | 32.59 | 15.50 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 23.35% | -26.16% |
Return on Equity (TTM) | 23.56% | -3.48% |
Debt to Equity (MRQ) | NA | 6.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.